Microarray Analysis Reveals Glucocorticoid-Regulated Survival Genes That Are Associated with Inhibition of Apoptosis in Breast Epithelial Cells

Cancer Research

Volumn 64, Issue 5, 2004, Pages 1757-1764

  Wu, Wei ^a   Chaudhuri, Shamita ^a   Brickley, Deanna R ^a   Pang, Diana ^a   Karrison, Theodore ^a   Conzen, Suzanne D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; OLIGONUCLEOTIDE; PACLITAXEL; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SMALL INTERFERING RNA; 3CH134 PROTEIN; CELL CYCLE PROTEIN; IMMEDIATE EARLY PROTEIN; NUCLEAR PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE; SGK PROTEIN;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSACTIVATION; BREAST TUMOR; CELL CULTURE; EPITHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELLS, CULTURED; DEXAMETHASONE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GLUCOCORTICOIDS; HUMANS; IMMEDIATE-EARLY PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 1642315292     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2546     Document Type: Article

References (43)

1. Greenstein, S., Ghias, K., Krett, N. L., and Rosen, S. T. Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin. Cancer Res., 8: 1681-1694, 2002.
2. Lipworth, B. J. Therapeutic implications of non-genomic glucocorticoid activity. Lancet, 356: 87-89, 2000.
3. Distelhorst, C. W. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ., 9: 6-19, 2002.
4. Moran, T. J., Gray, S., Mikosz, C. A., and Conzen, S. D. The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res., 60: 867-872, 2000.
5. Schorr, K., and Furth, P. A. Induction of bcl-xL expression in mammary epithelial cells is glucocorticoid-dependent but not signal transducer and activator of transcription 5-dependent. Cancer Res., 60: 5950-5953; 2000.
6. Bailly-Maitre, B., de Sousa, G., Boulukos, K., Gugenheim, J., and Rahmani, R. Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction. Cell Death Differ., 8: 279-288, 2001.
7. Newton, C. J., Xie, Y. X., Burgoyne, C. H., Adams, I., Atkin, S. L., Abidia, A., and McCollum, P. T. Fluvastatin induces apoptosis of vascular endothelial cells: blockade by glucocorticoids. Cardiovasc. Surg. 11: 52-60, 2003.
8. Weinstein, R. S., Chen, J. R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., and Manolagas, S. C. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Investig, 109: 1041-1048, 2002.
9. Clark, A. R. MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids? J. Endocrinol, 178: 5-12, 2003.
10. Huang, Y., Johnson, K. R., Norris, J. S., and Fan, W. Nuclear factor-κB/IκB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res., 60: 4426-4432, 2000.
11. Herr, I., Ucur, E., Herzer, K., Okouoyo, S., Ridder, R., Krammer, P. H., Von Knebel Doeberitz, M., and Debatin, K. M. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res., 63: 3112-3120, 2003.
12. Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A., and Greenberg, M. E. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol., 21: 952-965, 2001.
13. Mikosz, C. A., Brickley, D. R., Sharkey, M. S., Moran, T. W., and Conzen, S. D. Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J. Biol. Chem., 276: 16649-16654, 2001.
14. Magi-Galluzzi, C., Mishra, R., Fiorentino, M., Montironi, R., Yao, H., Capodieci, P., Wishnow, K., Kaplan, I., Stork, P., and Loda, M. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis. Lab. Investig., 76: 37-51, 1997.
15. Castillo, S. S., and Teegarden, D. Sphingosine-1-phosphate inhibition of apoptosis requires mitogen-activated protein kinase phosphatase-1 in mouse fibroblast C3H10T(1/2) cells. J. Nutr., 133: 3343-3349, 2003.
16. Wang, H., Cheng, Z., and Malbon, C. Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. Cancer Lett., 191: 229-237, 2003.
17. Denkert, C., Schmitt, W., Berger, S., Reles, A., Pest, S., Siegert, A., Lichtenegger, W., Dietel, M., and Hauptmann, S. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma. Int. J. Cancer, 102: 507-513, 2002.
18. Liao, Q., Guo, J., Kleeff, J., Zimmermann, A., Buchler, M., Korc, M., and Friess, H. Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. Gastroenterology, 124: 1830-1845, 2003.
19. Affymetrix I. GeneChip Expression Analysis Technical Manual. Santa Clara, CA: Affymetrix, Inc., 2002.
20. Webster, M. K., Goya, L., Ge, Y., Maiyar, A. C., and Firestone, G. L. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol. Cell. Biol., 13: 2031-2040, 1993.
21. Chang, T. C., Hung, M. W., Jiang, S. Y., Chu, J. T., Chu, L. L., and Tsai, L. C. Dexamethasone suppresses apoptosis in a human gastric cancer cell line through modulation of bcl-x gene expression. FEBS Lett., 415: 11-15, 1997.
22. Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O'Shea, J. J., Chrousos, G. P., and Bornstein, S. R. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J., 16: 61-71, 2002.
23. Franchimont, D., Galon, J., Vacchio, M. S., Fan, S., Visconti, R., Frucht, D. M., Geenen, V., Chrousos, G. P., Ashwell, J. D., and O'Shea, J. J. Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor α. J. Immunol., 168: 2212-2218, 2002.
24. Brickley, D. R., Mikosz, C. A., Hagan, C. R., and Conzen, S. D. Ubiquitin modification of serum and glucocorticoid-induced protein kinase-1 (SGK-1). J. Biol. Chem., 277: 43064-43070, 2002.
25. Gewirtz, D. A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochem. Pharmacol., 57: 727-741, 1999.
26. Gotaskie, G. E., and Andreassi, B. F. Paclitaxel: a new antimitotic chemotherapeutic agent. Cancer Pract., 2: 27-33, 1994.
27. Hudis, C. A. The current state of adjuvant therapy for breast cancer: focus on paclitaxel. Semin. Oncol., 26: 1-5, 1999.
28. Sunters, A., Fernandez de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., and Lam, E. W. F. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J. Biol. Chem., 278: 49795-49805, 2003.
29. Leong, M. L., Maiyar, A. C., Kim, B., O'Keeffe, B. A., Firestone, G. L. Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J. Biol. Chem., 278: 5871-5882, 2003.
30. Brondello, J., Pouyssegur, J., and McKenzie, F. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science (Wash. DC), 286: 2514-2517, 1999.
31. Amsterdam, A., and Sasson, R. The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis. Mol. Cell. Endocrinol., 189: 1-9, 2002.
32. Wang, Z., Malone, M., He, H., M. K., and Distelhorst, C. Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J. Biol. Chem., 278: 23861-23867, 2003.
33. Wan, Y., and Nordeen, S. Overlapping but distinct profiles of gene expression elicited by glucocorticoids and progestins. Recent Prog. Horm. Res., 58: 199-226, 2002.
34. Shang, Y., and Brown, M. Molecular determinants for the tissue specificity of SERMs. Science (Wash. DC), 295: 2465-2468, 2002.
35. Planey, S. L., Abrams, M. T., Robertson, N. M., and Litwack, G. Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. Cancer Res., 63: 172-178, 2003.
36. Pae, H. O., Yoo, J. C., Choi, B. M., Kim, T. Y., and Chung, H. T. Protective effects of glucocorticoids on Taxol-induced cytotoxicity in human leukemia HL-60 cells. Immunopharmacol. Immunotoxicol., 21: 439-453, 1999.
37. Wolff, J. E., Denecke, J., and Jurgens, H. Dexamethasone induces partial resistance to cisplatinum in C6 glioma cells. Anticancer Res., 16: 805-809, 1996.
38. Uozumi, J., Koikawa, Y., Yasumasu, T., Tokuda, N., and Kumazawa, J. The protective effect of methylprednisolone against cisplatin-induced nephrotoxicity in patients with urothelial tumors. Int. J. Urol., 3: 343-347, 1996.
39. Zhang, B., Tang, E., Zhu, T., Greenberg, M., Vojtek, A., and Guan, K. Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf. J. Biol. Chem., 276: 31620-31626, 2001.
40. Bacus, S., Gudkov, A., Lowe, M., L. L., Yung, Y., Komarov, A., Keyomarsi, K., Yarden, Y., and Seger, R. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene, 20: 147-155, 2001.
41. Zelivianski, S., Spellman, M., Kellerman, M., Kakitelashvilli, V., Zhou, X. W., Lugo, E., Lee, M. S., Taylor, R., Davis, T. L., Hauke, R., and Lin, M. F. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int. J. Cancer, 107: 478-485, 2003.
42. Brantley-Finley, C., Lyle, C. S., Du, L., Goodwin, M. E., Hall, T., Szwedo, D., Kaushal, G. P., and Chambers, T. C. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. Biochem. Pharmacol., 66: 459-469, 2003.
43. Widen, C., Zilliacus, J., Gustafsson, J. A., and Wikstrom, A. C. Glucocorticoid receptor interaction with 14-3-3 and Raf-1, a proposed mechanism for cross-talk of two signal transduction pathways. J. Biol. Chem., 275: 39296-39301, 2000.